biotech / news / / International Business Times
TrumpRx is a US government-linked website designed to lower drug prices for patients.
Johnson & Johnson will sell four prescription drugs through the TrumpRx platform for lower prices.
KEY POINTS
- Participation in TrumpRx comes in exchange for trade benefits, including certain tariff exemptions for Johnson & Johnson.
- The deal expands lower-priced drug access to Americans enrolled in Medicaid and other assistance programs.
- Johnson & Johnson announced a $55 billion investment in US research and manufacturing, including new facilities.
COMPANIES
Summarized by Newsio from International Business Times. How we summarize →